Olatunji OM
No ORCID on file
· 2 papers in corpus
· active 2022-2023
Top journals
Frequent coauthors
- Fatumo S 2
- Ijagbuji A 2
- Nash O 2
- Oyinloye B 2
- Omotuyi O 2
- Soremekun O 2
2023
Benzimidazole compound abrogates SARS-COV-2 receptor-binding domain (RBD)/ACE2 interaction In vitro.
The development of clinically actionable pharmaceuticals against coronavirus disease (COVID-19); an infectious disease caused by the SARS-CoV-2 virus is very important for ending the pandemic. Coronavirus spike glycoprotein (GP)-Receptor Bi…
2022
Abstract Coronavirus spike glycoprotein (GP)-Receptor Binding Domain (RBD) and its interaction with host receptor angiotensin converting enzyme 2 (ACE2) is one of the most structurally understood but therapeutically untapped aspect of COVI…